Financhill
Back

Humacyte Stock Predictions

Humacyte Stock Forecast

  • Is Humacyte Stock Undervalued?
    The current Humacyte [HUMA] share price is $4.10. The Score for HUMA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • HUMA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Humacyte Stock Go Up Next Year?

Data Unavailable

Humacyte Stock Rating

Data Unavailable

Humacyte Stock Price History

Is HUMA stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HUMA is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
humacyte.com

52-Week Data

52-Week High:
9.97
52-Week Low:
2.48

Prediction Charts

Market Cap:
527.54M
Price in USD:
4.10
Volume:
1.63M
Beta:
1.40

Technical Analysis

SMA50:
5.01
SMA100:
5.71
SMA200:
5.41
52-Wk Change:
40.89%

Stock Predictions

  • Is Humacyte stock public?
    Yes, Humacyte is a publicly traded company.
  • What is the Humacyte stock quote today?
    The Humacyte stock price is 4.10 USD today.
  • How to buy Humacyte stock online?
    You can buy Humacyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 4.47 4.28 4.64 4.22
Nov-26 4.24 4.43 4.49 4.12
Nov-27 4.44 4.40 4.74 4.39
Nov-29 4.44 4.52 4.54 4.41
Dec-2 4.56 4.45 4.65 4.34
Dec-3 4.45 4.25 4.49 4.18
Dec-4 4.25 4.43 4.44 4.25
Dec-5 4.53 4.49 4.58 4.40
Dec-6 4.50 4.83 5.03 4.48
Dec-9 4.80 4.22 4.85 4.21
Dec-10 4.30 4.26 4.45 4.24
Dec-11 4.25 4.27 4.33 4.10
Dec-12 4.36 4.08 4.38 4.05
Dec-13 4.12 4.10 4.22 4.01

Humacyte Earnings

Data Unavailable

Humacyte Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.41 per share.

* Humacyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.